New T Cell Therapy reagent for mRNA delivery using Lipid Nanoparticles

Precision NanoSystems is proud to announce that the GenVoy-ILM™ T Cell Kit for mRNA is now available to enable lipid nanoparticle (LNP)-based ex vivo gene transfer into T cells. Scientists can now use mRNA-LNP to efficiently and reproducibly generate high yields of engineered primary human T cells using a simple workflow.   Read the full press release here     One preparation is ready in under 5 minutes, and the resulting mRNA-LNPs can be seamlessly integrated into standard T cell culture workflows. The GenVoy-ILM T Cell Kit for mRNA and the NanoAssemblr® Spark™  enable the preparation of mRNA encapsulating LNP optimized for delivery to activated primary human T cells. It can be used at various stages of cell therapy research from discovery to preclinical development.   mRNA-LNP generated from the GenVoy-ILM T Cell Kit for mRNA leverage endogenous cellular uptake mechanisms   View the data     Webinar: Rethink T Cell Therapy with Lipid Nanoparticles  Learn more about how the GenVoy-ILM T Cell Kit for mRNA can empower your research. Key learnings: •    Review of current ex vivo gene delivery strategies for cell therapies •    Introduction of GenVoy lipid nanoparticle delivery platform •    Presentation of data in T cells comparing the GenVoy-ILM T Cell Kit for mRNA with electroporation   To watch the recording click here

Request training or a demo Click here for sample testing Click here for service support